{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:02:12Z","timestamp":1789171332828,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.radonc.2023.109976","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T02:33:51Z","timestamp":1698806031000},"page":"109976","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["What is the predictive value of RECIST criteria following stereotactic lung radiation?"],"prefix":"10.1016","volume":"190","author":[{"given":"Stephanie","family":"Gulstene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pencilla","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Melody Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna M.","family":"Laba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Yaremko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George B.","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Qiabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Malthaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalilah","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard I.","family":"Inculet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109976_b0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.prro.2017.04.014","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung cancer: Executive summary of an ASTRO evidence-based guideline","volume":"7","author":"Videtic","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109976_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2022.08.027","article-title":"Stereotactic ablative radiotherapy in the treatment of early-stage lung cancer \u2013 A done deal?","author":"Gulstene","year":"2022","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109976_b0015","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.radonc.2011.12.018","article-title":"Radiographic changes after lung stereotactic ablative radiotherapy (SABR) - Can we distinguish recurrence from fibrosis? A systematic review of the literature","volume":"102","author":"Huang","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109976_b0020","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20160113","article-title":"Pulmonary imaging after stereotactic radiotherapy-does RECIST still apply?","volume":"89","author":"Mattonen","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.radonc.2023.109976_b0025","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2023.109976_b0030","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jamaoncol.2018.1251","article-title":"Stereotactic body radiation therapy for operable early-stage lung cancer findings from the NRG oncology RTOG 0618 trial","volume":"4","author":"Timmerman","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2023.109976_b0035","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ijrobp.2015.07.2260","article-title":"A randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG oncology RTOG 0915 (NCCTG N0927)","volume":"93","author":"Videtic","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109976_b0040","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1200\/JCO.18.00622","article-title":"Safety and efficacy of a five-fraction stereotactic body radiotherapy schedule for centrally located non\u2013small-cell lung cancer: NRG Oncology\/RTOG 0813 trial","volume":"37","author":"Bezjak","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109976_b0045","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1001\/jama.2010.778","article-title":"Stereotactic body radiation therapy for inoperable lung cancer","volume":"303","author":"Timmerman","year":"2010","journal-title":"JAMA - J Am Med Assoc"},{"key":"10.1016\/j.radonc.2023.109976_b0050","unstructured":"Chmura S, Salama JK, Borges VF, White JR, Al-hallaq H, Matuszak M. NRG ONCOLOGY A Phase IIR \/ III Trial of Standard of Care Therapy with or without Stereotactic Body Radiotherapy (SBRT) and \/ or Surgical Ablation for Newly Oligometastatic Breast Cancer This trial is part of the National Clinical Trials Network (NCTN). ClinicalTrialsGov 2022. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT02364557 (accessed August 14, 2023)."},{"key":"10.1016\/j.radonc.2023.109976_b0055","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cllc.2016.08.002","volume":"18","author":"Swaminath","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.radonc.2023.109976_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/dju164","article-title":"Phase II study of accelerated hypofractionated three-dimensional conformal radiotherapy for stage T1\u20133 N0 M0 non-small cell lung cancer: NCIC CTG BR.25","volume":"106","author":"Cheung","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2023.109976_b0065","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-5977-6","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of 4\u201310 oligometastatic tumors (SABR-COMET-10): Study protocol for a randomized phase III trial","volume":"19","author":"Palma","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.radonc.2023.109976_b0070","doi-asserted-by":"crossref","unstructured":"Ball PD, Kron T, Chesson BApplSc B, Wirth A, Wheeler MBBS G, Shaw MBChB M, et al. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial. Articles Lancet Oncol 2019;20:494\u2013503. https:\/\/doi.org\/10.1016\/S1470-2045(18)30896-9.","DOI":"10.1016\/S1470-2045(18)30896-9"},{"key":"10.1016\/j.radonc.2023.109976_b0075","doi-asserted-by":"crossref","unstructured":"Palma DA, A Haasbeek CJ, Rodrigues GB, Dahele M, Lock M, Yaremko B, et al. Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial 2012. https:\/\/doi.org\/10.1186\/1471-2407-12-305.","DOI":"10.1186\/1471-2407-12-305"},{"key":"10.1016\/j.radonc.2023.109976_b0080","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamaoncol.2023.0161","article-title":"Addition of metastasis-directed therapy to intermittent hormone therapy for oligometastatic prostate cancer","volume":"9","author":"Tang","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2023.109976_b0085","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnci\/djac015","article-title":"Randomized trial of first-line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR-mutated non-small cell lung cancer","volume":"115","author":"Wang","year":"2023","journal-title":"JNCI"},{"key":"10.1016\/j.radonc.2023.109976_b0090","doi-asserted-by":"crossref","unstructured":"Palma DA, Nguyen TK, Louie A v., Malthaner R, Fortin D, Rodrigues GB, et al. Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial. JAMA Oncol 2019;5:681\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2018.6993.","DOI":"10.1001\/jamaoncol.2018.6993"},{"key":"10.1016\/j.radonc.2023.109976_b0095","doi-asserted-by":"crossref","unstructured":"Bogaerts J, Ford R, Sargent D, Schwartz LH, Rubinstein L, Lacombe D, et al. Individual patient data analysis to assess modifications to the RECIST criteria 2008. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.027.","DOI":"10.1016\/j.ejca.2008.10.027"},{"key":"10.1016\/j.radonc.2023.109976_b0100","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijrobp.2016.04.003","article-title":"Validation of high-risk computed tomography features for detection of local recurrence after stereotactic body radiation therapy for early-stage non-small cell lung cancer","volume":"96","author":"Peulen","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109976_b0105","doi-asserted-by":"crossref","unstructured":"Kim T-H, Woo S, Halpenny DF, Kim YJ, Yoon SH, Suh CH. Can high-risk CT features suggest local recurrence after stereotactic body radiation therapy for lung cancer? A systematic review and meta-analysis 2020. https:\/\/doi.org\/10.1016\/j.ejrad.2020.108978.","DOI":"10.1016\/j.ejrad.2020.108978"},{"key":"10.1016\/j.radonc.2023.109976_b0110","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3109\/0284186X.2012.731525","article-title":"Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: A quantitative analysis of CT density changes","volume":"52","author":"Mattonen","year":"2013","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.radonc.2023.109976_b0115","doi-asserted-by":"crossref","unstructured":"Lee K, Le T, Hau E, Hanna GG, Harriet Gee yy, Shalini Vinod xx, et al. A Systematic Review Into the Radiologic Features Predicting Local Recurrence After Stereotactic Ablative Body Radiotherapy (SABR) in Patients With Non-Small Cell Lung Cancer (NSCLC). Int J Radiation Oncol Biol Phys 2022;113:2022. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.11.027.","DOI":"10.1016\/j.ijrobp.2021.11.027"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402389870X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402389870X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T09:10:57Z","timestamp":1734253857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402389870X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":23,"alternative-id":["S016781402389870X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109976","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What is the predictive value of RECIST criteria following stereotactic lung radiation?","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109976","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109976"}}